Gregory D Davis Sangamo Therapeutics, Inc (SGMO) insider trading activity

Gregory D Davis is Head of Research & Technology of SANGAMO THERAPEUTICS, INC. Currently has a direct ownership of 166,358 shares of SGMO, which is worth approximately $118,114. The most recent transaction as insider was on Feb 25, 2025, when has been sold 507 shares (Common Stock) at a price of $0.96 per share, resulting in proceeds of $486. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 166K

17.59% 3M change

n/a 12M change

Total Value Held $118,114

Gregory D Davis Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 25 2025	SELL Payment of exercise price or tax liability	$486 $0.96 p/Share	507 Reduced 0.3%	166,358 Common Stock
Feb 25 2025	BUY Grant, award, or other acquisition	-	49,726 Added 18.71%	216,084 Common Stock
Feb 24 2025	SELL Payment of exercise price or tax liability	$705 $1.0 p/Share	705 Reduced 0.42%	166,865 Common Stock
Jan 22 2025	SELL Payment of exercise price or tax liability	$35,024 $1.15 p/Share	30,456 Reduced 15.38%	167,570 Common Stock
Nov 25 2024	SELL Payment of exercise price or tax liability	$979 $1.94 p/Share	505 Reduced 0.25%	201,863 Common Stock
Nov 24 2024	SELL Payment of exercise price or tax liability	$1,355 $1.88 p/Share	721 Reduced 0.36%	202,368 Common Stock

GDD

Gregory D Davis

Head of Research & Technology

Richmond, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SGMO shares.

Notify only if

Value

Insider Trading

Get notified when an Sangamo Therapeutics, Inc insider buys or sells SGMO shares.

Notify only if

Operation

Value

Type

News

Receive news related to SANGAMO THERAPEUTICS, INC

Track Activities on SGMO

Account